ALPHAPHARM Pty Ltd has advised the Therapeutic Goods Administration that stock levels of EpiPen (adult) will not return to normal for some months.
Currently supply of the adrenaline auto-injectors is constrained due to manufacturing delays, with Mylan Australia having created a dedicated EpiPen Customer Service Toll-Free hotline on 1800 931 625 to address enquiries.
The company also noted it was working closely with the Australasian Society of Clinical Immunology & Allergy, as well as Allergy & Anaphalaxys Australia.
Mylan has advised patients that despite the supply issues stock continues to be distributed, but warned they may need to leave prescriptions at the pharmacy while stock is ordered.
Pharmacists should contact primary wholesalers to obtain stock, and continue to place orders even if the wholesaler portal indicates no stock because "stock is being shipped continually".
Orders should be refreshed on a weekly basis, as back orders are being cancelled after any partial shipment of stock to pharmacies.
Mylan has also advised pharmacists who are encountering problems with ordering stock to email au.sales.support@mylan.com "to obtain instructions on how to access direct supply".
Supply of EpiPen Jnr 150mcg is not affected.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Apr 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Apr 18
